Research Sites

Clinical trial recruitment follow-up SLA examples

Operational SLA examples for clinical trial recruitment follow-up, including first response, prescreen review, records requests, scheduling readiness, and stale-lead review.

A recruitment follow-up SLA should define how quickly each handoff is reviewed, who owns the next step, and when stale work is escalated before patient interest loses momentum.

In this guide

Key points

  • Follow-up SLAs work best when they separate first response, prescreen review, records readiness, scheduling, and stale-lead escalation.
  • The SLA should create owner and due-date clarity without implying medical eligibility or guaranteed screening.
  • Weekly review should compare SLA misses by source, study, site, owner, blocker, and next action.

Start with the moments where interest stalls

A clinical trial recruitment SLA should be built around handoffs, not abstract speed. The highest-risk points are usually first response, prescreen completion, coordinator review, records request, scheduling readiness, and stale-lead follow-up.

The goal is not to promise that every patient will screen or enroll. The goal is to make sure every patient inquiry has a clear owner, a timely next action, and a respectful close-out path when the study team determines the person should not continue.

Use practical SLA windows

A simple first version can set expectations like same-business-day ownership for new inquiries, one business day for first outreach, two business days for prescreen review after completion, two business days for records-request review, and a weekly stale-lead sweep.

Teams should adjust those windows by study complexity, staffing, visit burden, and source type. A high-touch referral source may need a different response expectation than a broad digital campaign, but both should still produce visible owner and next-action fields.

Define what counts as meaningful movement

A status update is not always meaningful movement. Useful movement includes first outreach attempted, patient responded, prescreen completed, records requested, records received, coordinator review completed, scheduling-ready, scheduled, closed as no response, or closed for an operational reason.

That definition keeps the SLA honest. If a lead is touched but no next action, due date, or owner changes, the team may still have a stale recruitment problem.

Review misses without blaming the queue

An SLA miss should start a workflow review. Was the issue source quality, coordinator capacity, missing records, unclear fit signals, scheduling constraints, or a patient who stopped responding? The answer decides the fix.

The weekly review should group misses by source, site, study, owner, blocker, and next action. That lets a site lead improve the workflow while keeping patient-specific details in the appropriate secure workspace.

Keep study-team boundaries clear

Follow-up SLAs should never imply that a patient is eligible, suitable, or guaranteed a screening visit. They only define the operational rhythm for reviewing interest and moving the next step forward when appropriate.

TrialsNest supports this kind of workflow by keeping source, owner, prescreen state, records readiness, stale risk, and next action visible. Authorized study teams still make final screening, eligibility, and enrollment decisions.

Sources and editorial notes

Published .

Written for recruitment operations teams setting follow-up expectations. It is workflow education only and does not replace study-team review or patient-specific decisions.

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading